1999 to 2019 Saw Increase in Substance Use+CVD-Related Mortality

Follow Drugslib on

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

THURSDAY, Jan. 11, 2024 -- From 1999 to 2019, there was an increase in mortality related to substance use (SU) plus cardiovascular disease (CVD), according to a study published online Jan. 10 in the Journal of the American Heart Association.

Abdul Mannan Khan Minhas, M.D., from the University of Mississippi Medical Center in Jackson, and colleagues identified SU+CVD-related deaths using Multiple Cause-of-Death Public Use record death certificates and examined trends in mortality.

There were 636,572 SU+CVD-related deaths between 1999 and 2019. The researchers found the age-adjusted mortality rates were pronounced in men, in American Indian or Alaska Native individuals, in nonmetropolitan/rural areas, and for alcohol-related deaths (22.5, 37.7, 15.2, and 9.09 per 100,000 population, respectively). From 1999 to 2019, there was an increase observed in overall SU+CVD-related age-adjusted mortality rates from 9.9 to 21.4, with an average annual percent change of 4.0. Across all subgroups, there were increases seen in SU+CVD-related average annual percent changes, which were pronounced among women (4.8 percent) and for American Indian or Alaska Native individuals, younger individuals, nonmetropolitan areas, and cannabis and psychostimulant users.

"We would like to see additional public health efforts to support comprehensive evaluation and management of substance use in the U.S. that includes clinician and patient education, as well as attention to socioeconomic factors that contribute to substance use," senior author Dmitry Abramov, M.D., from the Loma Linda University Medical Center in California, said in a statement.

One author disclosed ties to the pharmaceutical industry.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-01-12 04:15

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords